Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications
2024 Standout
2 intermediate papers

Works of Sid Selva‐Nayagam being referenced

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
2010
Endemic Melioidosis in Tropical Northern Australia: A 10‐Year Prospective Study and Review of the Literature
2000

Author Peers

Author Last Decade Papers Cites
Sid Selva‐Nayagam 90 412 50 102 9 556
Fabián Andrés Rosas Romero 360 234 72 31 13 614
Jessica Hopkins 90 430 77 23 17 620
David L. Shriner 162 251 88 26 10 495
Jesse M. Hofflin 60 422 134 18 10 631
Angela Stein 55 162 34 71 14 617
Michael Stek 52 136 49 23 17 539
Tammy Ojo 62 276 141 11 10 498
John Barrett 135 220 11 15 13 565
Hongdong Tan 17 136 45 263 17 500
Sarah A. Myers 218 170 33 10 18 485

All Works

Loading papers...

Rankless by CCL
2026